Synopsys

Filing under Item 2.02 indicates Synopsys issued its quarterly results, with Item 9.01 covering the accompanying press release exhibit. PMs should focus on EDA/IP revenue growth, design-start trends tied to AI silicon demand, and any update to FY guidance post-Ansys integration. Full filing body not analyzed; description inferred from form + item codes.

Quarterly filing covering the period ended 2026-04-30, likely containing EDA/IP revenue, design-services backlog, and any early commentary on the Ansys acquisition integration. Full filing body not analyzed; description inferred from form + item codes. PMs should watch for China export-control exposure, AI/HPC design-start commentary, and FY26 guidance updates.

Combination of Reg FD forward guidance/commentary (Item 7.01) and an unregistered equity sale (Item 3.02) with supporting exhibits — likely tied to financing or M&A consideration (plausibly Ansys-related closing mechanics) paired with refreshed outlook commentary. Full filing body not analyzed; description inferred from form + item codes. PMs should check the exhibits for guidance deltas and dilution/issuance size before reacting.

8-K under Items 2.02 and 9.01 indicates Synopsys issued its quarterly/annual earnings release with accompanying exhibits (likely press release and financial tables). PMs should focus on EDA revenue growth, AI-driven design tool demand, Ansys deal integration commentary, and FY26 guidance versus consensus. Full filing body not analyzed; description inferred from form + item codes.

Annual report covering Synopsys's FY2025 (ended 2025-10-31), the first full year reflecting the Ansys acquisition closure and integration. PMs should focus on EDA/IP segment growth, AI-design tool traction with TSMC/Samsung/hyperscaler customers, China export-control exposure, and FY2026 guidance — all key reads for the KR/TW semi supply chain. Full filing body not analyzed; description inferred from form + item codes.

8-K combines a Regulation FD disclosure (Item 7.01) — typically updated forward commentary or management remarks — with an officer/director change (Item 5.02). PM relevance hinges on whether 7.01 contains new guidance or color on the Ansys integration, EDA demand, and China exposure, and on the seniority of the personnel change. Full filing body not analyzed; description inferred from form + item codes.

Synopsys filed its Q1 FY26 10-Q covering the quarter ended Jan 31, 2026 — the first reporting period likely consolidating the Ansys acquisition, making segment mix, deferred-revenue trends, and updated FY26 guidance the key items for PMs tracking EDA/semi-design exposure. Full filing body not analyzed; description inferred from form + item codes.

8-K covers Item 2.02 (earnings results) with 8.01 other material disclosure and 9.01 supporting exhibits, indicating Synopsys posted quarterly results and likely updated guidance. PMs should watch EDA/IP segment growth, design-start trends tied to AI chip demand, and any color on the Ansys integration. Full filing body not analyzed; description inferred from form + item codes.

Synopsys filed an 8-K under Item 8.01 (Other Material Events) with supporting exhibits under Item 9.01. Item 8.01 is a catch-all used for voluntary disclosures the company deems material — could range from litigation updates to deal-related communications or regulatory matters tied to the pending Ansys transaction. Full filing body not analyzed; description inferred from form + item codes — PMs holding SNPS or trading the Ansys arb spread should pull the exhibit before sizing.

Filing combines Item 5.02 (officer/director changes), Item 5.07 (shareholder vote results, typically annual meeting outcomes), and supporting exhibits (9.01). Full filing body not analyzed; description inferred from form + item codes. PM relevance is limited unless 5.02 involves a CEO/CFO transition — otherwise treat as routine governance housekeeping around the annual meeting.